128 related articles for article (PubMed ID: 11382721)
1. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project.
El-Khairy L; Ueland PM; Refsum H; Graham IM; Vollset SE;
Circulation; 2001 May; 103(21):2544-9. PubMed ID: 11382721
[TBL] [Abstract][Full Text] [Related]
2. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.
El-Khairy L; Ueland PM; Nygård O; Refsum H; Vollset SE
Am J Clin Nutr; 1999 Dec; 70(6):1016-24. PubMed ID: 10584046
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
[TBL] [Abstract][Full Text] [Related]
5. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
Moat SJ; Bonham JR; Powers HJ
Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
[TBL] [Abstract][Full Text] [Related]
6. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis.
van den Brandhof WE; Haks K; Schouten EG; Verhoef P
Atherosclerosis; 2001 Aug; 157(2):403-9. PubMed ID: 11472740
[TBL] [Abstract][Full Text] [Related]
7. Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate.
Boddie AM; Steen MT; Sullivan KM; Pasquali M; Dembure PP; Coates RJ; Elsas LJ
Metabolism; 1998 Feb; 47(2):207-11. PubMed ID: 9472972
[TBL] [Abstract][Full Text] [Related]
8. Physical training decreases total plasma homocysteine and cysteine in middle-aged subjects.
Gaume V; Mougin F; Figard H; Simon-Rigaud ML; N'Guyen UN; Callier J; Kantelip JP; Berthelot A
Ann Nutr Metab; 2005; 49(2):125-31. PubMed ID: 15860911
[TBL] [Abstract][Full Text] [Related]
9. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Melenovsky V; Stulc T; Kozich V; Grauova B; Krijt J; Wichterle D; Haas T; Malik J; Hradec J; Ceska R
Am Heart J; 2003 Jul; 146(1):110. PubMed ID: 12851616
[TBL] [Abstract][Full Text] [Related]
10. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
[TBL] [Abstract][Full Text] [Related]
11. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
12. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers.
Sobczak A; Wardas W; Zielinska-Danch W; Pawlicki K
Clin Chem Lab Med; 2004 Apr; 42(4):408-14. PubMed ID: 15147151
[TBL] [Abstract][Full Text] [Related]
13. Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study.
El-Khairy L; Vollset SE; Refsum H; Ueland PM
Clin Chem; 2003 Jun; 49(6 Pt 1):895-900. PubMed ID: 12765985
[TBL] [Abstract][Full Text] [Related]
14. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
15. Assessment of vitamin B-12, folate, and vitamin B-6 status and relation to sulfur amino acid metabolism in neonates.
Minet JC; Bissé E; Aebischer CP; Beil A; Wieland H; Lütschg J
Am J Clin Nutr; 2000 Sep; 72(3):751-7. PubMed ID: 10966894
[TBL] [Abstract][Full Text] [Related]
16. Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study.
El-Khairy L; Vollset SE; Refsum H; Ueland PM
Am J Clin Nutr; 2003 Feb; 77(2):467-72. PubMed ID: 12540409
[TBL] [Abstract][Full Text] [Related]
17. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study.
El-Khairy L; Vollset SE; Refsum H; Ueland PM
Clin Chem; 2003 Jan; 49(1):113-20. PubMed ID: 12507967
[TBL] [Abstract][Full Text] [Related]
18. High-throughput and simultaneous measurement of homocysteine and cysteine in human plasma and urine by liquid chromatography-electrospray tandem mass spectrometry.
Rafii M; Elango R; Courtney-Martin G; House JD; Fisher L; Pencharz PB
Anal Biochem; 2007 Dec; 371(1):71-81. PubMed ID: 17727809
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?
Elshorbagy AK; Nurk E; Gjesdal CG; Tell GS; Ueland PM; Nygård O; Tverdal A; Vollset SE; Refsum H
Am J Clin Nutr; 2008 Sep; 88(3):738-46. PubMed ID: 18779291
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
